Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2016-09-30
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
NCT06033599
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
NCT06032559
Motivational Interviewing and Guided Opioid Tapering Support to Promote Postoperative Opioid Cessation
NCT03659734
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.
NCT03212794
Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy
NCT03022890
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To date, few PA studies have been conducted with substance abusing populations - and, only one small pilot study with MMT patients. The goal of this project is to develop a feasible, acceptable and effective multilevel PA intervention that addresses both individual and interpersonal factors that can be easily scalable and delivered in the context of a health care setting (i.e., methadone clinics). To do so, the investigators are proposing to train MMT patients who are already engaging in PA at public health recommended levels to deliver a group-based PA intervention to physically inactive MMT patients at SSTAR Lifeline, a large community-based methadone clinic in Fall River, Massachusetts. Peer-facilitated interventions for self-management skills are common in the care of patients with chronic medical conditions. Peers may play a particularly important role in increasing physical activity in MMT, as this population faces unique and significant barriers to PA (e.g., depression, smoking, minimal social supports). Through the development of interpersonal relationships, the investigators expect that MMT peers who have successfully navigated these challenges will help physically inactive MMT patients increase self-efficacy and motivation for initiating and sustaining PA.
The aims of the study include:
1. PHASE 1 (Peer-PA Manual Development):
* To develop a theoretically-informed peer-facilitated PA plus Fitbit (Peer-PA+Fitbit) intervention specific to SSTAR Lifeline, in order to help patients in MMT increase levels of physical activity.
1. Focus groups will be conducted with: 1) MMT patients who are currently physically active and 2) MMT patients who are NOT meeting recommended PA levels to help inform intervention development.
2. The investigators will: (1) develop a manualized Peer-PA intervention (that includes the use of a Fitbit activity monitor for self-monitoring PA and additional social networking), (2) create a training protocol for MMT patients to become peer-facilitators, and (3) identify safe, walkable paths in participant neighborhoods.
2. PHASE 2 (Open Pilot):
* An open pilot trial will be conducted with 20 MMT patients to determine the feasibility, acceptability, and short term increases in PA of the Peer-PA+Fitbit intervention. At the end of 3 months:
1. Feedback will be obtained on Peer-PA+Fitbit from both the MMT peers and participants through self-report measures and qualitative interviews.
2. Adherence to the intervention will be determined through group attendance and Fitbit data.
3. Short-term increases in physical activity levels will be examined through objectively measured PA.
3. PHASE 3 (Randomized Clinical Trial; RCT)
To conduct a 3-arm preliminary RCT of Peer-PA+Fitbit compared to Fitbit Only and compared to Usual Care (UC) among 150 MMT patients. We hypothesize that, Peer-PA+Fitbit will be superior to Fitbit Only and that Fitbit Only will be superior to UC on the following:
1. Higher levels of short-term (3-month) and long-term (6- and 12-month) objectively-measured steps/day and moderate-to-vigorous physical activity (MVPA)
2. Fewer days of drug use and lower levels of depression and anxiety symptoms at each follow-up
3. Higher levels of theoretically-relevant, PA-related variables including: self-efficacy, internal motivation, and social support at 3- and 6-month follow-ups
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peer-PA+Fitbit
Participants will engage in a 12-week physical activity intervention guided by a peer-facilitator at the methadone clinic they receive treatment. Participants will attend weekly groups, engage in a guided walking group, and utilize the Fitbit to self-monitor physical activity.
Peer-Facilitated Counseling
Participants will engage in a 12-week physical activity intervention guided by a peer-facilitator at the methadone clinic they receive treatment. Participants will attend weekly groups, engage in a guided walking group, and utilize the Fitbit to self-monitor physical activity.
Fitbit activity tracker
Participants will be given a Fitbit activity tracker to monitor physical activity.
Fitbit Only
Participants will be given a Fitbit activity tracker along with brief advice for increasing physical activity.
Fitbit activity tracker
Participants will be given a Fitbit activity tracker to monitor physical activity.
Usual Care
Participants do not receive any intervention but participate in the assessments only.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peer-Facilitated Counseling
Participants will engage in a 12-week physical activity intervention guided by a peer-facilitator at the methadone clinic they receive treatment. Participants will attend weekly groups, engage in a guided walking group, and utilize the Fitbit to self-monitor physical activity.
Fitbit activity tracker
Participants will be given a Fitbit activity tracker to monitor physical activity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* low active (i.e., less than 90 minutes of MIPA per week for the past 6 months)
* has access to a computer connected to the internet or a smartphone compatible with the Fitbit application
Exclusion Criteria
* current suicidality or homicidality
* marked organic impairment according to responses to the diagnostic assessments
* physical or medical problems that would not allow safe participation in a program of moderate intensity physical activity (i.e., not medically cleared by methadone clinic physician)
* current pregnancy or intent to become pregnant during the next 12 weeks
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Butler Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana M Abrantes, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Butler Hospital
Michael Stein, M.D.
Role: PRINCIPAL_INVESTIGATOR
Boston University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanley Street Treatment and Resources (SSTAR) Lifeline
Fall River, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1609-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.